GSTK1 (AISSA et al.)is known to be associated with erlotinib-specific metabolic reprogramming and oxidative stress response, and ALDH3A1 (PU et al.)is a marker of paclitaxel resistance in lung cancer. This evidence concerns the gene ALDH3A1 and lung carcinoma.